The Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Level, Complication D
Transrectal ultrasound (TRUS)-guided prostate biopsy is one of the most commonly performed urological procedures today. This technique involves the insertion of a needle through the rectal mucosa to access the prostate. While TRUS-guided biopsy demonstrates a high detection rate for prostate cancer, it also carries a s
| Condition(s) | Prostate Cancer |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Transrectal ultrasound (TRUS)-guided prostate biopsy is one of the most commonly performed urological procedures today. This technique involves the insertion of a needle through the rectal mucosa to access the prostate. While TRUS-guided biopsy demonstrates a high detection rate for prostate cancer, it also carries a significant risk of post-procedural complications, such as hematuria, rectal bleeding, urinary retention, and anemia. Compared to other biopsy methods, TRUS-guided biopsy is associated with higher rates of hospital readmissions and an increased risk of infection and sepsis. These complications contribute to elevated healthcare costs, prolonged hospital stays, increased workload for healthcare providers, heightened patient stress and anxiety levels, greater analgesic requiremen |
| Who can participate | Inclusion Criteria: * Patients who agree to participate in the study, * Patients over the age of 18 * Patients who are conscious, oriented, and cooperative, * Patients who have no communication problems, * Patients who are scheduled to undergo their first prostate biopsy under transrectal ultrasound guidance, * Patients who have no mental disorders, * Patients who have not been diagnosed with anxiety disorder, * Patients not taking medication for anxiety control. Exclusion Criteria: * Patients who refuse to participate in the study, * Patients under the age of 18 * Patients who are conscious, oriented, and uncooperative, * Patients with communication problems, * Patients who have not undergone transrectal ultrasound-guided prostate biopsy, * Patients who have previously undergone prostate |
| Ages | 18 Years |
| Sex | Male |
| Lead sponsor | Mersin University |
| Locations | Mersin, Turkey (Türkiye); Mersin, Turkey (Türkiye) |
| Start date | 2025-06-01 |
| NCT ID | NCT06998121 |
| Official listing | https://clinicaltrials.gov/study/NCT06998121 |